Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 160 results for copd

  1. The percentage of patients with coronary heart disease, stroke or TIA, diabetes, hypertension, peripheral arterial disease, heart failure, COPD, asthma and/ or rheumatoid arthritis who have had a BMI recorded in the preceding 12 months

    TIA, diabetes, hypertension, peripheral arterial disease, heart failure, COPD, asthma and/ or rheumatoid arthritis who have had a BMI...

    General practice indicator suitable for use in the QOF
    Published
    4 November 2020

  2. The percentage of patients with COPD on the register, who have had a review in the preceding 12 months, including a record of the number of exacerbations and an assessment of breathlessness using the Medical Research Council dyspnoea scale.

    NM170

    General practice indicator suitable for use in the QOF
    Published
    29 March 2022

  3. Impact of multi-disciplinary involvement to improve smoking cessation in the acute admissions unit (AMU)

    services – these patient groups (and COPD) present to AMU. NICE NG15 COPD guidance re-iterates that fundamentals of...

    Shared learning
    Last updated
    30 April 2021

  4. The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 12 months

    the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma who are recorded as current smokers who...

    General practice indicator suitable for use in the QOF
    Published
    27 August 2021

  5. The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses whose notes record smoking status in the preceding 12 months

    NICE indicators. NM38 smoking cessation guidance.

    General practice indicator suitable for use in the QOF
    Published
    5 April 2022

  6. Prophylactic antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who are at high risk of exacerbations are most likely to benefit from prophylactic antibiotics?

    antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who are at high risk of exacerbations are most...

    Research recommendation
    Published
    6 February 2019

  7. The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 12 months

    NICE indicators. NM39 smoking cessation.

    General practice indicator suitable for use in the QOF
    Published
    26 November 2021

  8. How to use quality standards

    How providers and commissioners can use quality standards to improve the quality of care

  9. Ensuring access to Pulmonary Rehabilitation for a deaf service user

    line with NICE guidance for diagnosis and management of chronic obstructive pulmonary disease (COPD) in over 16's (NG115)....

    Shared learning
    Last updated
    7 February 2020

  10. Developing a new pulmonary rehabilitation program tailored for interstitial lung disease with Newcastle upon Tyne Hospitals' Interstitial Lung Disease service

    extensive evidence for PR in patients suffering from chronic obstructive pulmonary disease (COPD) but much less for ILD....

    Shared learning
    Last updated
    23 May 2019

  11. Pulmonary hypertension:- What are the most clinical and cost-effective treatments for pulmonary hypertension in people with COPD?

    clinical and cost-effective treatments for pulmonary hypertension in people with COPD? Any explanatory notes(if applicable) N/A Source...

    Research recommendation
    Published
    13 February 2019

  12. Multidimensional assessment of outcomes- How can the individual factors associated with COPD prognosis (collected from a range of sources including primary care, imaging and pulmonary rehabilitation results) be combined into a multidimensional analysis that provides accurate and useful information on prognosis?

    Multidimensional assessment of outcomes- How can the individual factors associated with COPD prognosis (collected from a range of...

    Research recommendation
    Published
    6 February 2019

  13. Mucolytic therapy:- In people with COPD, does mucolytic drug therapy prevent exacerbations in comparison with placebo and other therapies?

    Recommendation ID NG115/11 Question Mucolytic therapy:- In people with COPD, does mucolytic drug therapy prevent exacerbations in...

    Research recommendation
    Published
    13 February 2019

  14. Inhaled corticosteroid responsiveness:- What features predict inhaled corticosteroid responsiveness most accurately in people with COPD?

    predict inhaled corticosteroid responsiveness most accurately in people with COPD? Any explanatory notes(if applicable) Why this is...

    Research recommendation
    Published
    6 February 2019

  15. Indicators

    NICE indicators on: cardiovascular disease prevention (risk assessment) COPD (annual review) postnatal support (6-week postnatal check)...